Literature DB >> 870266

Cramps, thirst and hypertension in hemodialysis patients -- the influence of dialyzate sodium concentration.

R Wilkinson, S G Barber, V Robson.   

Abstract

The effect of increasing dialyzate sodium concentration from 130 to 136 mmoles/l on the incidence of muscle cramps in patients on regular dialysis treatment is assessed. This change was found to be effective in markedly reducing the incidence of cramp at the cost of a slight rise in the complaint of thirst. Mean arterial pressure rose slightly but significantly and exchangeable sodium was increased to levels comparable to those measured during 1969, when with twice weekly dialysis hypertension was a problem. It is concluded that dialyzate sodium concentration may with benefit be increased to 136 mmoles/l, provided that blood pressure is carefully monitored.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 870266

Source DB:  PubMed          Journal:  Clin Nephrol        ISSN: 0301-0430            Impact factor:   0.975


  6 in total

Review 1.  Optimal dialysate sodium-what is the evidence?

Authors:  Finnian R Mc Causland; Sushrut S Waikar
Journal:  Semin Dial       Date:  2014-01-23       Impact factor: 3.455

Review 2.  Dialysate Sodium: Rationale for Evolution over Time.

Authors:  Jennifer E Flythe; Finnian R Mc Causland
Journal:  Semin Dial       Date:  2017-01-08       Impact factor: 3.455

3.  Sodium retention and hypertension with short dialysis.

Authors:  L Sellars; V Robson; R Wilkinson
Journal:  Br Med J       Date:  1979-02-24

4.  Unexpected seizures during hemodialysis. Effect of dialysate prescription.

Authors:  D M Ford; R J Portman; D L Hurst; G M Lum
Journal:  Pediatr Nephrol       Date:  1987-10       Impact factor: 3.714

5.  Rationale and design of the Sodium Lowering In Dialysate (SoLID) trial: a randomised controlled trial of low versus standard dialysate sodium concentration during hemodialysis for regression of left ventricular mass.

Authors:  Joanna Leigh Dunlop; Alain Charles Vandal; Janak Rashme de Zoysa; Ruvin Sampath Gabriel; Imad Adbi Haloob; Christopher John Hood; Philip James Matheson; David Owen Ross McGregor; Kannaiyan Samuel Rabindranath; David John Semple; Mark Roger Marshall
Journal:  BMC Nephrol       Date:  2013-07-15       Impact factor: 2.388

6.  Low dialysate sodium levels for chronic haemodialysis.

Authors:  Joanna L Dunlop; Alain C Vandal; Mark R Marshall
Journal:  Cochrane Database Syst Rev       Date:  2019-01-16
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.